awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34307050-8F82853A-CE0A-484F-92A8-018DE18BA032
Q34307050-8F82853A-CE0A-484F-92A8-018DE18BA032
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34307050-8F82853A-CE0A-484F-92A8-018DE18BA032
A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.
P2860
Q34307050-8F82853A-CE0A-484F-92A8-018DE18BA032
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34307050-8F82853A-CE0A-484F-92A8-018DE18BA032
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d5155d86c2a8448096931120205f687f59b63e4
P2860
Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.